Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 04/03/2025
DUE: 05/07/2027
The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICOs) are issuing this notice of funding opportunity (NOFO) seeking appli...
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 01/07/2028
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding ...
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 05/04/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of...
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 01/07/2027
The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health th...
Co-infection and Cancer (R21 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 01/07/2026
The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestab...
Co-infection and Cancer (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 01/07/2026
This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer.
Preference will be given t...
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 01/07/2028
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applicat...
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 03/31/2025
DUE: 01/07/2028
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applicat...
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 10/08/2027
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of th...
Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 02/13/2026
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit competitive revision (formerly known as competitive supplement) applications from awardees with active U19 awards funded under RF...